Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo
Clinical trial NCT02993406 · COMPLETED
Trial details
- NCT number
- NCT02993406
- Sponsor
- Esperion Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2022-11-07
- Enrollment
- 13970
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.